Abstract

Human serum binding protein for vitamin D and its metabolites. I. Physicochemical and immunological identification in human tissues.

Highlights

  • The physicochemical and immunological characteristics of the human tissue binding protein for 25-hydroxycholecalciferol (25-OH-D3) were studied

  • On sucrose gradients (Fig. 2), iodinated DBP co-sedimented with 25OHj3H]D3 bound to serum, and both were less dense than the bovine serum albumin marker

  • As reported previously for rat muscle [15], the 25-OH-r3H]D3 bound by human skeletal muscle cytosol sedimented in the 5 to 6 S region, faster than bovine serum albumin

Read more

Summary

Introduction

The physicochemical and immunological characteristics of the human tissue binding protein for 25-hydroxycholecalciferol (25-OH-D3) were studied. The ‘251-labeled complex was dissociated by 6 M guanidine HCl or sodium dodecyl sulfate (SDS) treatment, resulting in “‘1 sucrose gradient sedimentation and SDS-polyacrylamide gel electrophoresis migration characteristic of the serum binding protein. These data provide clear evidence that the tissue binding protein represents an interionic association between an unidentified tissue factor and the serum binding protein. Human serum DBP has been isolated and partially characterized in several laboratories (l-3) It is a 3.5 S, M, = 58,000 single polypeptide chain which has a binding preference for 25-OH-D3 over vitamin D3 and 1,25-

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.